- Home
- Media centre
- Press release archive
Press release archive
[an error occurred while processing this directive] [an error occurred while processing this directive]
12 May 2008
Lapatinib (Tykerb/Tyverb) to be investigated in landmark early breast cancer trial
02 May 2008
GlaxoSmithKline commences tender offer to acquire Sirtris Pharmaceuticals
30 April 2008
FDA approves Advair 250/50 for reduction of exacerbations in patients with COPD
30 April 2008
GSK announces changes to Corporate Executive Team
29 April 2008
GlaxoSmithKline awards £300,000 to community health charities in recognition of their work
25 April 2008
GSK receives positive opinion for conditional approval of new oral breast cancer treatment, Tyverb (lapatinib)
23 April 2008
Results announcement for the first quarter 2008
22 April 2008
GlaxoSmithKline to acquire Sirtris Pharmaceuticals, a world leader in 'Sirtuin' research and development
22 April 2008
GlaxoSmithKline reports further progress of oncology portfolio
15 April 2008
Treximet (sumatriptan and naproxen sodium) tablets approved by FDA for acute treatment of migraine
08 April 2008
GlaxoSmithKline confirms receipt of FDA letter on regulatory reporting
02 April 2008
GlaxoSmithKline statement - Lancet publication of D:A:D data
19 March 2008
GSK charitable support valued at GBP282 million in 2007
18 March 2008
Tyverb (lapatinib) European regulatory update
06 March 2008
GSK statement on MHRA investigation
03 March 2008
FDA grants Priority Review For Promacta / Revolade (Eltrombopag)
29 February 2008
Update on GSK's malaria treatments: Dacart and Lapdap
28 February 2008
XenoPort and GlaxoSmithKline report positive top-line results of final pivotal trial of XP13512/GSK1838262 for restless legs syndrome
26 February 2008
GlaxoSmithKline statement: Public Library of Science Medicine article on antidepressant medicines
26 February 2008
GlaxoSmithKline and Theravance announce expansion of the Horizon programme with start of large Phase 2B study of LABA in COPD patients
21 February 2008
GSK's Volibris (ambrisentan) receives EMEA positive opinion for approval to treat class II and II pulmonary arterial hypertension (PAH)
21 February 2008
GSK receives favourable recommendation by FDA advisory committee for Rotarix [rotavirus, live, oral]
19 February 2008
New price reductions for GSK antiretrovirals in the world's poorest countries
08 February 2008
FDA extends review of NDA for Entereg® (alvimopan)
07 February 2008
Full-year results announcement 2007
06 February 2008
GlaxoSmithKline responds to findings in ACCORD study
04 February 2008
GlaxoSmithKline and Amira Pharmaceuticals enter global agreement for FLAP inhibitor programme
31 January 2008
GlaxoSmithKline files pneumococcal paediatric vaccine in the EU
28 January 2008
GlaxoSmithKline welcomes European guidance that stockpiling more than one antiviral would be useful in preparing for a flu pandemic
28 January 2008
GlaxoSmithKline and Synta announce elesclomol granted US orphan drug designation by the FDA
24 January 2008
GSK appoints Lon Cardon to focus genetics on new disease targets
24 January 2008
GSK and MRC to identify new therapeutic targets and biomarkers from genetic association studies
24 January 2008
GlaxoSmithKline and TB Alliance renew tuberculosis drug discovery programme
24 January 2008
GlaxoSmithKline and Medicines For Malaria Venture announce new collaboration to investigate novel antimalarial compounds
24 January 2008
GlaxoSmithKline to revise Avandia® (rosiglitazone maleate) label in Europe following assessment by CHMP
15 January 2008
New allergic rhinitis treatment Avamys™ approved in Europe
15 January 2008
GlaxoSmithKline and XenoPort report positive top-line results of second phase 3 restless legs syndrome trial for XP13512/GSK1838262
03 January 2008
GlaxoSmithKline and Theravance announce start of large Phase 2B ICS and LABA studies for asthma in the Horizon programme
[an error occurred while processing this directive] [an error occurred while processing this directive]
20 December 2007
GlaxoSmithKline files for FDA approval of Promacta/Revolade (eltrombopag) to be the first oral platelet growth factor for rare blood disorder
19 December 2007
GlaxoSmithKline and Santaris Pharma enter global R&D alliance to discover, develop and commercialise RNA antagonists as novel antivirals
19 December 2007
GlaxoSmithKline completes acquisition of Reliant Pharmaceuticals
17 December 2007
GlaxoSmithKline receives FDA ‘complete response’ letter for cervical cancer vaccine
16 December 2007
GlaxoSmithKline announces data on Tykerb® (lapatinib) plus capecitabine for the treatment of HER2-positive breast cancer brain metastases
14 December 2007
GlaxoSmithKline receives positive EMEA opinion for a conditional approval of Tyverb®
13 December 2007
GlaxoSmithKline presents innovative neuroscience pipeline
11 December 2007
GlaxoSmithKline responds to JAMA article on the ICES thiazolidinediones and cardiovascular outcomes in older patients with diabetes
10 December 2007
GlaxoSmithKline receives decision from US FDA on Requip® XL™
10 December 2007
Long-term safety and efficacy data on Promacta™ (eltrombopag) presented at American Society of Hematology Annual Meeting
10 December 2007
GlaxoSmithKline and OncoMed Pharmaceuticals form strategic alliance to develop cancer stem cell antibody therapeutics
10 December 2007
GlaxoSmithKline and Galapagos enter strategic alliance to develop novel antibacterials and antivirals
07 December 2007
GlaxoSmithKline announces appointments to the Board of Directors
06 December 2007
GSK’s continued commitment to fighting HIV/AIDS results in approval of new formulations of three medicines for the treatment of children
03 December 2007
GSK response to Nature Medicine article on rosiglitazone and bone in mice
28 November 2007
GSK statement on US Food and Drug Administration Pediatric Advisory Committee recommendations regarding salmeterol
26 November 2007
GlaxoSmithKline obtains exclusive US OTC marketing rights to Mevacor® (lovastatin) from Merck & Co., Inc.
21 November 2007
GlaxoSmithKline to acquire Reliant Pharmaceuticals
20 November 2007
GlaxoSmithKline and Genmab initiate ofatumumab rheumatoid arthritis Phase III programme
15 November 2007
GSK and the European Foundation for the Study of Diabetes (EFSD) commit €1 million to diabetes research in Europe
14 November 2007
GlaxoSmithKline revises US labeling for Avandia
07 November 2007
Prometheus to acquire Lotronex® from GlaxoSmithKline
05 November 2007
New innovation grants boost malaria advocacy efforts in Africa
02 November 2007
Fabre Kramer Pharmaceuticals receives decision from FDA on gepirone ER for major depressive disorder
24 October 2007
Results announcement for the third quarter 2007
23 October 2007
GlaxoSmithKline and Tolerx form worldwide collaboration for development and commercialisation of novel medication
19 October 2007
New allergic rhinitis treatment Avamys™ receives positive opinion in Europe
18 October 2007
European Medicine Agency (EMEA) confirms positive Avandia benefit risk assessment
17 October 2007
New Lancet study: Malaria vaccine candidate has promising safety, tolerability profile in infants
15 October 2007
GSK receives approval for Hycamtin® (topotecan) capsules for the treatment of relapsed small cell lung cancer
10 October 2007
GlaxoSmithKline and Synta Pharmaceuticals announce development and commercialisation collaboration for STA-4783 in oncology
08 October 2007
GlaxoSmithKline appoints Andrew Witty CEO designate
08 October 2007
GlaxoSmithKline and Anacor Pharmaceuticals form alliance to develop systemic antivirals and antibiotics based on boron chemistry
04 October 2007
GSK seeks prequalification for Cervarix™ from the World Health Organization after obtaining marketing approval in Europe
02 October 2007
GSK applies for licence to market OTC weight loss product In Europe
28 September 2007
GSK submits Cervarix licence application to Japan's health authorities
28 September 2007
GlaxoSmithKline plc announces change to the Board of Directors
27 September 2007
GlaxoSmithKline helps form the Serious Adverse Events Consortium
25 September 2007
GlaxoSmithKline named to Working Mother "100 Best Companies" list
24 September 2007
Cervarix, GSK's cervical cancer vaccine, approved In Europe
21 September 2007
GSK receives decision from FDA on Lamictal®XR™ Extended-Release Tablets
11 September 2007
GlaxoSmithKline and Sepracor Inc. announce international alliance for commercialisation of Lunivia
11 September 2007
GlaxoSmithKline responds to JAMA articles
04 September 2007
Study shows combination therapy incorporating Avodart® and tamsulosin provides continuous symptom improvement over two years
03 September 2007
GlaxoSmithKline's Arixtra® receives European authorisation for the treatment of acute coronary syndromes
28 August 2007
FDA accepts for review complete response to approvable letter for Entereg® (alvimopan) for POI
16 August 2007
GlaxoSmithKline signs contract for its pandemic flu vaccine with UK Government
14 August 2007
GlaxoSmithKline's application for Rotarix® is accepted for review by the FDA
14 August 2007
GlaxoSmithKline updates prescribing information for Avandia in the US
08 August 2007
GSK gives consent under Canada's Access to Medicines Regime for generic version of HIV/AIDS medicine for use in Rwanda
08 August 2007
GSK receives decision from FDA on Advair 500/50 for COPD
03 August 2007
GlaxoSmithKline receives new HHS order for H5N1 bulk antigen
02 August 2007
FDA issues second approvable letter for Trexima™
02 August 2007
GSK comments on UK Government announcement to renegotiate current Pharmaceutical Pricing and Regulation Scheme agreement
30 July 2007
GlaxoSmithKline presents Avandia data to FDA
30 July 2007
Pharmetrics epidemiology study
30 July 2007
FDA Advisory Panel votes 22 to 1 for Avandia® to remain available to patients in the US
27 July 2007
GlaxoSmithKline statement in diabetes care study thiazolidinediones and heart failure: a teleo-analysis [1]
27 July 2007
GlaxoSmithKline and Targacept form alliance in therapeutics for CNS-related disorders
25 July 2007
New head-to-head study comparing Lexiva® and atazanavir show similar efficacy and lipid changes
25 July 2007
Results announcement for the second quarter 2007
17 July 2007
GSK responds to online review of rosiglitazone by The Cochrane Collaboration
09 July 2007
GSK receives extended licence indication for Seretide in Europe following submission of TORCH data for COPD
18 June 2007
GlaxoSmithKline expects to launch up to five major new medicines for oncology in next three years
13 June 2007
GlaxoSmithKline to make unprecedented vaccine donation to WHO pandemic flu stockpile
13 June 2007
GlaxoSmithKline's application for DTaP-IPV vaccine is accepted for review by the FDA
12 June 2007
alli™ - the OTC weight loss product - on shelves nationwide in the US later this week
11 June 2007
GlaxoSmithKline and Adolor update alvimopan (Entereg/Entrareg) development programme
06 June 2007
Newly published data from large study support cardiovascular safety of Avandia (rosiglitazone maleate)
06 June 2007
Statement of Moncef Slaoui, PhD, Chairman Research & Development, GlaxoSmithKline
05 June 2007
GlaxoSmithKline response to New England Journal of Medicine editorials
04 June 2007
Eight-year long-term data demonstrate prolonged overall survival and length of disease remission with BEXXAR
01 June 2007
GlaxoSmithKline announces Altargo approved in Europe for treatment of Impetigo and other skin infections
01 June 2007
GlaxoSmithKline honours cancer research pioneer Gianni Bonadonna with new ASCO award and fellowship
30 May 2007
Data affirms Avandia (rosiglitazone maleate) cardiovascular safety profile
24 May 2007
GlaxoSmithKline launches Chinese R&D centre with appointment of head in Shanghai
23 May 2007
GlaxoSmithKline announces Swiss approval of Tyverb®, a new oral treatment for advanced breast cancer
23 May 2007
GlaxoSmithKline plc - results of AGM
22 May 2007
alli™ debuts through the alli Experience
21 May 2007
Cervarix™ is approved in Australia for females 10-45 years old
21 May 2007
GlaxoSmithKline responds to NEJM article on Avandia
21 May 2007
GlaxoSmithKline strongly defends its record on Avandia
08 May 2007
Fabre-Kramer refiles gepirone ER with the FDA for the treatment of major depressive disorder
02 May 2007
Trexima™ (sumatriptan/naproxen sodium) demonstrated efficacy across multiple migraine attacks
01 May 2007
New data shows once a day Lamictal® XR™ is effective in treating patients with partial seizures
30 April 2007
GlaxoSmithKline and Wellcome Trust announce partnership to target drug-resistant hospital infections
25 April 2007
Results announcement for the first quarter 2007
18 April 2007
GlaxoSmithKline receives Japanese approval for two major new product opportunities: Seretide/Advair and Arixtra
18 April 2007
Community health charities receive £265,000 in recognition of their work from GlaxoSmithKline
12 April 2007
GSK initiates repeat dosing study of its novel oral platelet growth factor, eltrombopag, in ITP
12 April 2007
GSK announces FDA approval of Altabax (retapamulin ointment), 1%
09 April 2007
GSK and Adolor announce preliminary results from phase 3 Safety study of Alvimopan (Entereg/Entrareg)
03 April 2007
Trexima (sumatriptan/naproxen sodium) superior efficacy data published in JAMA
02 April 2007
GlaxoSmithKline KK seeks approval in Japan for lapatinib, a new treatment for breast cancer
02 April 2007
FDA approves accelerated dosing schedule for GlaxoSmithKline's Twinrix
30 March 2007
GlaxoSmithKline files meningococcal conjugate vaccine
29 March 2007
GlaxoSmithKline submits biologics license application to US Food and Drug Administration for Cervarix
29 March 2007
GlaxoSmithKline appoints Zhi Hong to head infectious-diseases research centre
26 March 2007
New study indicates nicotine patches may be safe for helping patients with coronary artery disease to quit smoking
22 March 2007
GSK announces nationwide availability of once-a-day Coreg CR for the treatment of three key cardiovascular conditions
20 March 2007
FiberChoice plus multivitamins issues allergy alert
09 March 2007
New JACC analysis details cardiovascular protective benefits of carvedilol in heart failure patients
05 March 2007
New studies indicate GSK's pre-pandemic influenza vaccine can protect against different strains of H5N1
01 March 2007
Study published in New England Journal of Medicine: Vaccine 95.5% effective against neglected hepatitis E
27 February 2007
New data show fluticasone furoate nasal spray effectively treated nasal symptoms of allergic rhinitis
26 February 2007
GSK initiates first global Phase III study of Tykerb (lapatinib) in head and neck cancer
21 February 2007
Landmark study shows important benefits of Seretide treatment for patients with fatal lung disease, COPD
20 February 2007
GlaxoSmithKline acquires exclusive rights to over-the-counter orlistat for markets outside the US from Roche Group
20 February 2007
OFT market study into the Pharmaceutical Price Regulation Scheme
16 February 2007
GlaxoSmithKline successfully completes tender offer for shares of Praecis Pharmaceuticals
16 February 2007
GlaxoSmithKline Diseases of the Developing World ad campaign receives industry award
13 February 2007
WHO awards prequalification status to GSK rotavirus vaccine
13 February 2007
GlaxoSmithKline and Human Genome Sciences announce initiation of Phase 3 clinical trial of Lymphostat-B in systemic lupus erythematosus
13 February 2007
GlaxoSmithKline offers new tools to help patients get free medicines
12 February 2007
GlaxoSmithKline plc announces change to the Board of Directors
09 February 2007
GlaxoSmithKline commends $1.5 billion advance market commitment for pneumococcal vaccines
08 February 2007
Full-year results announcement 2006
08 February 2007
GlaxoSmithKline and XenoPort announce agreement on late-stage compound for RLS and neuropathic pain
08 February 2007
GlaxoSmithKline and Fabre-Kramer Pharmaceuticals enter global agreement for new treatment of major depressive disorder
07 February 2007
FDA approves alli (orlistat 60 mg capsules) over-the-counter
07 February 2007
GlaxoSmithKline accepts shares in tender offer for shares of Praecis Pharmaceuticals and commences subsequent offering period
02 February 2007
GlaxoSmithKline receives approvable letter for new indications for Arixtra (fondaparinux sodium) injection
02 February 2007
Valtrex (valacyclovir) - US patent litigation update
29 January 2007
GlaxoSmithKline statement - BBC Panorama - 29 January 2007
29 January 2007
GlaxoSmithKline files its new pre-pandemic influenza vaccine in Europe
18 January 2007
GlaxoSmithKline initiates head-to-head study of cervical cancer vaccines
16 January 2007
GlaxoSmithKline receives first European approval for Wellbutrin XR
09 January 2007
GlaxoSmithKline commences tender offer to acquire Praecis Pharmaceuticals
[an error occurred while processing this directive] [an error occurred while processing this directive]
27 December 2006
Landmark Tykerb (lapatinib) data published in the New England Journal of Medicine
22 December 2006
GSK receives approvable letter for topical antibiotic, Altabax (retapamulin ointment), 1%
21 December 2006
GlaxoSmithKline to acquire Praecis Pharmaceuticals
19 December 2006
GlaxoSmithKline and Genmab enter global agreement for HuMax-CD20
19 December 2006
Adrian Rawcliffe to lead GlaxoSmithKline's Worldwide Business Development
19 December 2006
GlaxoSmithKline completes acquisition of CNS, Inc.
18 December 2006
GlaxoSmithKline discontinues clinical development of investigational protease inhibitor brecanavir (640385)
15 December 2006
GlaxoSmithKline reaches EU regulatory milestone in its flu pandemic vaccine development programme
13 December 2006
Lapatinib (Tykerb) to be evaluated in early stage disease in adjuvant breast cancer settings internationally
12 December 2006
GlaxoSmithKline and EPIX Pharmaceuticals enter drug discovery and development alliance
08 December 2006
GlaxoSmithKline to acquire Domantis for £230 million
06 December 2006
Novel oral platelet growth factor, eltrombopag, to be evaluated in long term ITP study
04 December 2006
Landmark study shows Avandia is more effective than metformin or a sulphonylurea in long-term blood sugar control in type 2 diabetes
01 December 2006
Hycamtin indication expanded to include treatment of cervical cancer in combination with chemotherapy
29 November 2006
GlaxoSmithKline welcomes decision by GAVI Alliance to support introduction of new vaccines against rotavirus and pneumococcal disease
29 November 2006
Bill Louv appointed Senior Vice President, Information Technology; Ford Calhoun to retire from GSK
20 November 2006
GSK to supply and store H5N1 vaccine products for US flu pandemic stockpiling
15 November 2006
GlaxoSmithKline and NeuroSearch expand the scope of strategic alliance
15 November 2006
National survey reveals striking lack of understanding about common, life-threatening lung disease that affects millions
13 November 2006
GlaxoSmithKline welcomes new GINA guidelines for Asthma Management and Prevention
13 November 2006
GSK joins with HHS and CDC to encourage flu vaccinations
11 November 2006
New data show fewer visits and hospitalizations among asthma patients treated with Advair Diskus
11 November 2006
New survey data reveal majority of asthma patients remain uncontrolled based on scores from the Asthma Control Test
06 November 2006
FDA issues approvable letter for Entereg for POI
30 October 2006
Eltrombopag significantly improved platelet count and allowed initiation of antiviral therapy in majority of hepatitis C patients
26 October 2006
Results announcement for the third quarter 2006
20 October 2006
FDA approves new, once-a-day COREG CR for the treatment of three key cardiovascular conditions
18 October 2006
Switzerland to purchase GSK's H5N1 vaccine for pre-pandemic use
18 October 2006
GlaxoSmithKline's new generation flu vaccine shows a significant increase in seroprotection rate in the over 65 population
12 October 2006
GlaxoSmithKline sponsors HIV Medicine Association Minority Fellowship Program
11 October 2006
GlaxoSmithKline submits supplemental drug application in the USA for Advair in COPD
09 October 2006
GlaxoSmithKline seeks European approval for Tykerb (lapatinib ditosylate) for the treatment of advanced breast cancer
09 October 2006
GlaxoSmithKline to acquire CNS, Inc.
05 October 2006
GSK's new flu vaccine, FluLaval, provides Americans with a new option for fighting the flu
02 October 2006
FDA grants priority review for Arixtra (fondaparinux sodium) in the treatment of acute coronary syndromes
29 September 2006
GlaxoSmithKline strengthens global vaccine manufacturing network with investment of Euros 500m in production facility in France
29 September 2006
Mathematical model predicts that Cervarix may prevent nearly 80% of cervical cancers
28 September 2006
GlaxoSmithKline grants license for manufacture of influenza treatment zanamivir
28 September 2006
New data reinforce efficacy of Trizivir alone in treatment-naive HIV patients with low viral load
28 September 2006
GlaxoSmithKline and Vertex Pharmaceuticals announce virologic and drug resistance results from protease inhibitor study
27 September 2006
GSK statement: Court of First Instance judgement
25 September 2006
FDA approves new epilepsy indication for Lamictal
25 September 2006
GlaxoSmithKline named to Working Mother Hall of Fame
20 September 2006
New data show consistent efficacy and tolerability of Trexima (sumatriptan succinate/naproxen sodium) across multiple migraine attacks
18 September 2006
GlaxoSmithKline seeks US approval for Tykerb (lapatinib ditosylate) for the treatment of advanced breast cancer
15 September 2006
GlaxoSmithKline agrees preferential prices for HIV medicines in Russia
15 September 2006
Avandia reduces risk of progression from pre-diabetes to type 2 diabetes by 62 per cent in largest ever diabetes prevention trial
12 September 2006
GlaxoSmithKline submits Seretide TORCH study data to EU regulators
11 September 2006
GSK settles transfer pricing tax dispute with IRS
08 September 2006
GlaxoSmithKline Award for Outstanding Achievement in Chemical Biology granted to Professor Herbert Waldmann, Max-Planck Institute
07 September 2006
Low-dose orlistat provides significant weight loss and multiple health benefits
05 September 2006
GlaxoSmithKline receives positive decision in Greek parallel trade case
05 September 2006
GlaxoSmithKline and Adolor report top line results from phase 3 studies of alvimopan (Entereg/Entrareg)
04 September 2006
New study reveals investigational 24-hour formulation of Requip (ropinirole HCI) tablets reduced "off" time for patients with Parkinson's disease
24 August 2006
GlaxoSmithKline and ChemoCentryx enter into drug discovery and development alliance in inflammatory disorders
24 August 2006
GlaxoSmithKline receives approval in 15 European countries for use of Relenza in prevention of influenza A and B
14 August 2006
Updated HIV treatment guidelines now include three GSK HIV medications for initial antiretroviral treatment regimens
10 August 2006
GSK patents and patent applications for Combivir
10 August 2006
GlaxoSmithKline reaches civil settlements on AWP matters
27 July 2006
New seasonal and perennial rhinitis intranasal treatment submitted for US and European marketing approval
27 July 2006
Sri Lanka conducts its final national lymphatic filariasis mass drug distribution
26 July 2006
GSK reports significant advance in H5N1 pandemic flu vaccine programme
26 July 2006
Results announcement for the second quarter 2006
24 July 2006
Pivotal studies begin for new antimalarial in sub-Saharan Africa
20 July 2006
GSK announces US government purchase of Relenza for state stockpiles
06 July 2006
Study finds that co-administration of LEXIVA with esomeprazole does not affect blood levels of LEXIVA
29 June 2006
GlaxoSmithKline plc announces change to the Board of Directors
22 June 2006
GlaxoSmithKline and INSEAD inaugurate a Chair in Corporate Innovation
13 June 2006
New treatment provides relief of both nasal and ocular symptoms in seasonal allergic rhinitis
07 June 2006
GlaxoSmithKline and Galapagos enter into drug discovery and development alliance in osteoarthritis
06 June 2006
PATH to pave the way for cervical cancer vaccines in the developing world
05 June 2006
GSK licenses cancer antigen portfolio from Ludwig Institute for Cancer Research
03 June 2006
GlaxoSmithKline reports positive new data on Tykerb (lapatinib ditosylate)
30 May 2006
GlaxoSmithKline takes further action to help the world's poorest countries fight HIV/AIDS
24 May 2006
GlaxoSmithKline demonstrates progress of oncology portfolio
24 May 2006
GlaxoSmithKline reports on data transparency
22 May 2006
Study identifies predictors of bipolar disorder risk
18 May 2006
Jennie Younger, SVP Corporate Communications & Community Partnerships to leave GSK
17 May 2006
GlaxoSmithKline extends JP Garnier's contract
17 May 2006
New data show Coreg CR reduced blood pressure in patients with essential hypertension
16 May 2006
GlaxoSmithKline and Vertex announce preliminary 48-week results from head-to-head clinical study
11 May 2006
GlaxoSmithKline announces transitional plan for former patient assistance program enrollees
10 May 2006
GSK obtains injunction to protect shareholders against animal extremists
10 May 2006
GSK wins World Business Award for efforts to end lymphatic filariasis
08 May 2006
GlaxoSmithKline condemns animal extremist letter campaign to shareholders
04 May 2006
GlaxoSmithKline and Adolor present positive results from a clinical study of alvimopan (Entereg)
04 May 2006
GlaxoSmithKline awarded $274 million HHS contract
03 May 2006
GSK receives positive opinion from CHMP on Seretide dosing for initial maintenance therapy
27 April 2006
Results announcement for the first quarter 2006
24 April 2006
Baby boom icon Sally Field takes on new leading role as women's health advocate
19 April 2006
Ten top health charities awarded £210,000 in GlaxoSmithKline IMPACT Awards 2006
13 April 2006
GlaxoSmithKline and Adolor announce the completion of enrolment of pivotal clinical studies of Entereg (alvimopan)
06 April 2006
Arixtra significantly reduced major bleeding compared to Lovenox in a study of patients with acute coronary syndromes
03 April 2006
GlaxoSmithKline and Sirna Therapeutics announce major alliance in RNAi-based therapeutics for respiratory disease
31 March 2006
New Bonviva quarterly injection approved in Europe for postmenopausal osteoporosis
30 March 2006
GlaxoSmithKline initiates human trial programme with two H5N1 pandemic flu vaccines
30 March 2006
GlaxoSmithKline and Pharmacopeia enter into drug discovery and development alliance
28 March 2006
GSK announces positive results of Seretide study in patients with chronic obstructive pulmonary disease (COPD)
24 March 2006
New data in Lancet confirm potential to eliminate lymphatic filariasis
23 March 2006
GlaxoSmithKline submits Biologics License Application for FDA approval of Flulaval
23 March 2006
FDA approves Flovent HFA( fluticasone propionate hfa) Inhalation Aerosol for children four to eleven
22 March 2006
Study shows Levitra treats erectile dysfunction effectively in men taking medications to lower high blood pressure
22 March 2006
GlaxoSmithKline begins testing new technology
22 March 2006
Eight local community health organizations honored for excellence at 9th Annual GlaxoSmithKline IMPACT Awards
21 March 2006
GlaxoSmithKline's CEO appointed to Chancellor Gordon Brown's International Business Advisory Council
21 March 2006
Patrick Vallance to head Drug Discovery at GlaxoSmithKline
17 March 2006
New study shows women with osteoporosis preferred once-monthly dosing of Boniva over a once-weekly medicine
14 March 2006
New Drug Application for Coreg CR accepted for review by U.S. Food and Drug Administration
09 March 2006
Marketing application for Cervarix, GSK's candidate caccine for cervical cancer, submitted in the European Union
09 March 2006
New analysis shows high narcotic use among headache sufferers
08 March 2006
New observational study suggests use of combination vaccines may improve immunization coverage rates in infants
07 March 2006
GSK statement regarding Flonase generic
06 March 2006
GlaxoSmithKline and Myogen announce pulmonary arterial hypertension partnership
03 March 2006
Response to global disasters increases GSK's giving by 16 per cent to £380m in 2005
03 March 2006
GSK announces new product labels for Serevent and Advair
01 March 2006
New study shows Ohioans needlessly suffer because they are not properly caring for chronic conditions
27 February 2006
Rotarix: first vaccine against rotavirus available in Europe
23 February 2006
New appointments at GlaxoSmithKline emphasize focus on development and medical governance
22 February 2006
GlaxoSmithKline supports the establishment of Improving Health for Ohioans month
14 February 2006
GlaxoSmithKline acquires PLIVA's Research Institute
14 February 2006
GlaxoSmithKline's topical antibacterial retapamulin accepted for review by the US Food and Drug Administration
13 February 2006
ARIXTRA was effective and well tolerated in acutely ill medical patients - treatment reduced risk of venous thromboembolism (VTE)
08 February 2006
Full-year results announcement 2005
07 February 2006
Adolor and GlaxoSmithKline report positive top-line results in phase 3 study 314 of Entereg (alvimopan) in postoperative ileus
06 February 2006
Dr. Moncef Slaoui to Head GlaxoSmithKline Research and Development
03 February 2006
Arixtra administered the morning after orthopedic surgery prevented venous thromboembolism with low risk of bleeding
02 February 2006
FDA approves new formulation of Imitrex (sumatriptan succinate) injection
01 February 2006
GSK confirms: Panadol is safe for consumers, when used as directed
01 February 2006
IV Hycamtin receives European marketing approval as treatment for relapsed small cell lung cancer
27 January 2006
European positive opinion for first quarterly I.V. injection for postmenopausal osteoporosis
23 January 2006
FDA Joint Advisory Committee recommends approval of orlistat 60mg capsules for over-the-counter use
19 January 2006
New study supports importance of considering gastric stasis
17 January 2006
GlaxoSmithKline plc Directorate change
06 January 2006
FDA approves first IV treatment for postmenopausal osteoporosis - Boniva Injection
04 January 2006
Requip (ropinirole HCl) tablets significantly improve symptoms of Restless Legs Syndrome (RLS) in patients with RLS
[an error occurred while processing this directive] [an error occurred while processing this directive]
22 December 2005
GlaxoSmithKline plc announces changes to the Board of Directors
21 December 2005
GlaxoSmithKline donates $1 million to rebuilding efforts in South Asia
19 December 2005
GSK presents data supporting development of investigational HIV drug brecanavir
19 December 2005
First in new class of antibacterials demonstrates promising activity against pathogens commonly found in skin infections
15 December 2005
GlaxoSmithKline's Rotarix vaccine against rotavirus receives a positive opinion from the European authorities
08 December 2005
GlaxoSmithKline acquires influenza vaccine manufacturer ID Biomedical Corporation
08 December 2005
Heartfelt wake-up call sounded for heart attack survivors
08 December 2005
GSK changes paroxetine prescribing information
30 November 2005
GlaxoSmithKline presents rapidly expanding pipeline of oncology and supportive care compounds
30 November 2005
Number of pills affects adherence to HIV treatment regimens
25 November 2005
£470,000 in research awards to aid medical advance into chronic diseases
24 November 2005
GlaxoSmithKline announces Hycamtin receives positive opinion in Europe for treatment of patients with relapsed small cell lung cancer
18 November 2005
GlaxoSmithKline and Malaria Consortium announce new partnership to expand international malaria advocacy
18 November 2005
GSK statement on FDA proposed labeling change for Serevent and Advair
18 November 2005
FDA approves updated labeling for GSK's Lexiva
17 November 2005
The University of Oxford and GlaxoSmithKline to collaborate In cancer research at leading clinical centres in India
17 November 2005
GSK donates 350,000 doses of hepatitis-A vaccine for children in Pakistan disaster relief camps
16 November 2005
Bonviva I.V. Injection for postmenopausal osteoporosis confirmed effective over two years
16 November 2005
New antimalarial combination confirms its potential use in treating drug-resistant malaria
16 November 2005
GlaxoSmithKline and the Congressional Black Caucus Foundation join forces to improve opportunities for small disadvantaged businesses
15 November 2005
New results show the RTS, S malaria vaccine candidate protects children for at least 18 months
11 November 2005
Assessment tool proven to measure level of asthma control in children
02 November 2005
GlaxoSmithKline vaccine adjuvant offers sustained enhanced immune response against cancer-causing human papillomavirus, new study shows
02 November 2005
GlaxoSmithKline underlines commitment to neglected diseases with new manufacturing investment in Africa
01 November 2005
Leading academic researchers join GlaxoSmithKline in pioneering clinical-imaging programme
28 October 2005
Arranon Injection approved by US FDA
27 October 2005
Results announcement for the third quarter 2005
25 October 2005
GlaxoSmithKline terminates patient enrollment for phase 3 studies of investigational HIV entry inhibitor aplaviroc (GW873140)
25 October 2005
Study shows children prefer taste of medication for GERD
20 October 2005
GlaxoSmithKline Biologicals and Aeras Global TB Vaccine Foundation partner to develop new TB vaccine
19 October 2005
GlaxoSmithKline initiates new HIV/AIDS collaboration in Kenya
18 October 2005
GlaxoSmithKline's Havrix (hepatitis A vaccine, inactivated) now approved for use in children aged 12 months and older
17 October 2005
Bone Diva calendar girls spur others to battle osteoporosis
14 October 2005
GSK statement: Pandemic flu plans
11 October 2005
GSK and Pozen announce Trexima (sumatriptan succinate and naproxen sodium) new drug application accepted for review by FDA
07 October 2005
GlaxoSmithKline CEO meets with President Bush to discuss pandemic flu plans
05 October 2005
New national survey indicates low awareness for pediatric GERD
27 September 2005
Study shows women with postmenopausal osteoporosis prefer new once monthly to weekly treatment
26 September 2005
Study shows women prefer once-monthly osteoporosis medicine over a once-weekly
26 September 2005
Roche and GSK announce head-to-head study of osteoporosis therapies
20 September 2005
GlaxoSmithKline to increase supply of paediatric vaccines
20 September 2005
GlaxoSmithKline, government reach civil settlement
19 September 2005
Once-monthly oral Bonviva approved for postmenopausal osteoporosis In Europe
19 September 2005
GlaxoSmithKline responds to hurricane relief needs
19 September 2005
New analysis revealed beta-blocker use at hospital discharge associated with reduced death rates among heart failure patients
16 September 2005
Committee for Medicinal Products for Human Use gives positive opinion on GlaxoSmithKline's Adartrel (ropinirole) for RLS (Restless Legs Syndrome)
15 September 2005
GlaxoSmithKline's Jack Ziegler to retire; John Clarke to succeed him as President, Consumer Healthcare
14 September 2005
FDA Ad Com recommends accelerated approval of Arranon (nelarabine) Injection
12 September 2005
GlaxoSmithKline and Adolor announce initiation of Phase 3 clinical studies of alvimopan in opioid-induced constipation
07 September 2005
GlaxoSmithKline to acquire ID Biomedical Corporation
05 September 2005
Arixtra showed comparable efficacy to Lovenox/Clexane with significantly less major bleeding in patients with acute coronary syndromes
01 September 2005
GlaxoSmithKline acquires vaccine R&D and manufacturing plant in the US
01 September 2005
Value of Medicines awareness month public education campaign
01 September 2005
GlaxoSmithKline aids hurricane relief efforts
31 August 2005
GlaxoSmithKline announces FDA approval of Fluarix
30 August 2005
Court dismisses federal antitrust claims in drug importation lawsuit
22 August 2005
GlaxoSmithKline response - The OsloSub-Analysis
22 August 2005
Mural art steers away from the streets and towards the gallery for charity
28 July 2005
Results Announcement for the Second Quarter 2005
27 July 2005
Patient satisfaction with once-daily dosing of HIV fixed-dose combination tablet Epzicom
26 July 2005
Epidemiology study reports new information on hypersensitivity reactions to Abacavir at a glance
26 July 2005
Long-term safety data of Lexiva/r in HIV patients co-infected with hepatitis
25 July 2005
GlaxoSmithKline begins Phase III trials with aplaviroc (873140) an entry inhibitor for HIV treatment
22 July 2005
Adolor receives FDA approvable letter for Entereg (alvimopan)
22 July 2005
GlaxoSmithKline launches free, online support program for patients with depression or anxiety disorders
20 July 2005
Cilag GmbH International to acquire nesiritide rights in Europe from GlaxoSmithKline
13 July 2005
FDA Advisory Committee recommends continued availability of Serevent for treatment of asthma
01 July 2005
GlaxoSmithKline to double flu vaccine production capacity through investment in Dresden plant
30 June 2005
GlaxoSmithKline reviews pipeline of novel vaccines with the potential to dramatically improve global health
29 June 2005
NicoDerm CQ gives 'the patch' a makeover
29 June 2005
Hollywood stars team up to help smokers quit for good and help prevent kids from starting
27 June 2005
Bonviva, first once-monthly oral tablet for osteoporosis, receives positive opinion in Europe
27 June 2005
GlaxoSmithKline announces resupply of Paxil CR to US market
27 June 2005
GSK Consumer Healthcare races towards NASCAR sponsor history again
21 June 2005
GSK Biologicals and IAVI partner to develop AIDS vaccine
17 June 2005
Open letter to the leaders of the G-8 nations
16 June 2005
Actor's child's battle with epilepsy inspires creation of Hollywood's helping hands fundraiser
15 June 2005
Corixa and GlaxoSmithKline announce expiration of Hart-Scott-Rodino waiting period
09 June 2005
New data confirm once-monthly oral treatment for osteoporosis is 'highly effective' over two years
09 June 2005
New study highlights long term effectiveness of ropinirole In Parkinson's disease
25 May 2005
GlaxoSmithKline plc - results of AGM
25 May 2005
GlaxoSmithKline submits Biologics License Application for FDA approval of Fluarix
19 May 2005
GlaxoSmithKline appoints new head for its venture capital business
18 May 2005
State of diabetes in America: a new report reveals America's diabetes health is in jeopardy
15 May 2005
GlaxoSmithKline issues update on Lapatinib: new clinical data and regulatory filing plans
11 May 2005
First ranking of big cities most at risk from osteoporosis
03 May 2005
FDA approved Boostrix a new US vaccine for adolescents against Pertussis
29 April 2005
Pharmacokinetic data on co-administraction of the PI Lexiva/r with the NRTI Tenofovir
29 April 2005
New pharmacokinetic data on taking Lexiva simultaneously with Nexium
29 April 2005
GlaxoSmithKline to acquire Corixa Corporation - developer of novel vaccine adjuvants and antigens
27 April 2005
GlaxoSmithKline and FDA reach agreement on consent decree regarding Cidra, Puerto Rico, manufacturing site.
19 April 2005
£200,000 awarded to 10 innovative health charities across the UK
12 April 2005
Roche and GlaxoSmithKline announce promotion agreement for Xenical in the US
08 April 2005
GlaxoSmithKline presents new data on investigational HIV compound, 873140, a CCR5 Antagonist
08 April 2005
GlaxoSmithKline statement on launch of the partnership for prescription assistance
15 March 2005
GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
08 March 2005
Publication of GSK's Form 20-F and review of earnings guidance
08 March 2005
GlaxoSmithKline and Adolor Report initial results from Phase 2 studies of Entereg (Alvimopan)
04 March 2005
GSK announces disruption of supply for Paxil CR and Avandamet
04 March 2005
Publication of GlaxoSmithKline's 2004 Annual Report 2004 Annual Review
28 February 2005
Kidney dysfunction in HIV patients may be detected earlier using estimated GFR
18 February 2005
New hope for highly dependent and heavy smokers
08 February 2005
The risk of both stroke and coronary heart disease (CHD) nearly doubles with elevated LP-PLA2 activity
07 February 2005
Ozone friendly formulation, Flovent HFA (fluticasone propionate HFA) inhalation aerosol, now available
04 February 2005
GlaxoSmithKline receives authorisation from European Commission for use of Arixtra in medical patients
02 February 2005
GlaxoSmithKline and Merck & Co., Inc. enter cross-license and settlement agreement for HPV vaccine patents
02 February 2005
Jerome Bettis' touchdown pass named "Levitra (vardenafil hci) Play of the Year"
26 January 2005
GSK receives notice from IRS on tax allocation dispute for 1997-2000
19 January 2005
Vesicare (solifenacin succinate) now available nationwide in US
12 January 2005
GlaxoSmithKline again to sponsor national NBC Health and Fitness Expos in 2005
11 January 2005
New Together Rx access card offers Americans with no prescription drug coverage savings at the pharmacy counter
11 January 2005
Football legend Joe Theismann launches campaign to boost awareness and treatment of enlarged prostate (EP)
10 January 2005
GSK's Levitra co-promotion rights transferred back to Bayer in most major markets outside the US
10 January 2005
GlaxoSmithKline's global launch with Rotarix starts in Mexico
10 January 2005
It's Migraine Awareness month: Do you know what type of headache you have?
06 January 2005
GlaxoSmithKline's response to the announcement by Pharmaceutical Association on the disclosure of clinical trial Information
04 January 2005
GlaxoSmithKline response to Tsunami Disaster - UPDATE
03 January 2005
GlaxoSmithKline announces expanded indication for Bexxar
02 January 2005
The tsunami tragedy - what GlaxoSmithKline is doing to help
Back to top
